Pharmacology - Drug Development

1 - 12 of 45 listings
Listings
  • Inactivated HAV Antigen (Human)

    Inactivated HAV Antigen (Human)

    Pharmacology - Drug Development Shirley (New York) August 29, 2019 Check with publisher

    The Hepatitis A virus (HAV), or Hepatovirus A, is a virus of the Picornaviridae family. It takes human and vertebrates as its natural hosts. HAV isolates all belong to a single serotype, seven genetic groups now have been defined, four for humans (ge...

  • Anti-CD22 (clone 10F4v3)-Mc-VC-PABC-MMAE ADC

    Anti-CD22 (clone 10F4v3)-Mc-VC-PABC-MMAE ADC

    Pharmacology - Drug Development Shirley (New York) August 27, 2019 Check with publisher

    This ADC product is comprised of an anti-CD22 monoclonal antibody (clone 10F4v3) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosi...

  • Recombinant Human CD226 Protein(Fc tag)

    Recombinant Human CD226 Protein(Fc tag)

    Pharmacology - Drug Development Shirley (New York) May 30, 2019 Check with publisher

    Receptor involved in intercellular adhesion, lymphocyte signaling, cytotoxicity and lymphokine secretion mediated by cytotoxic T-lymphocyte (CTL) and NK cell. Recombinant Human CD226 Protein (Q15762) (Glu 19 - Asn 247) with a human IgG1 Fc tag at the...

  • Recombinant Human IL13 Protein

    Recombinant Human IL13 Protein

    Pharmacology - Drug Development Shirley (New York) April 28, 2019 Check with publisher

    Cytokine (PubMed:8096327, PubMed:8097324). Inhibits inflammatory cytokine production (PubMed:8096327). Synergizes with IL2 in regulating interferon-gamma synthesis (PubMed:8096327). May be critical in regulating inflammatory and immune responses (Pub...

  • Auditing Physician Contracts Under the New Stark Rules

    Auditing Physician Contracts Under the New Stark Rules

    Pharmacology - Drug Development Fremont (California) March 1, 2019 Check with publisher

    Overview: In this session Mr. Wolfe will provide an overview of the Stark Law, including its recent changes. He will also discuss best practices for auditing physician compensation arrangements on behalf of health systems, hospitals, medical groups a...

  • Recombinant Mouse Tnf, None tagged

    Recombinant Mouse Tnf, None tagged

    Pharmacology - Drug Development Shirley (New York) February 26, 2019 Check with publisher

    Cat.No.: Tnf-484M Product Overview: Recombinant Mouse Tnf (NP_038721.1) soluble form (Leu 80-Leu 235), fused with an initial Met at the C-terminus, was produced in E. coli. Source: E. coli Species: Mouse Form: Lyophilized from sterile 50mM Tris 0.2M ...

  • ZSCAN4 peptide

    ZSCAN4 peptide

    Pharmacology - Drug Development Shirley (New York) February 22, 2019 Check with publisher

    The ZSCAN4 gene encodes a protein involved in telomere maintenance and with a key role in the critical feature of mouse embryonic stem (ES) cells, namely, defying cellular senescence and maintaining normal karyotype for many cell divisions in culture...

  • Wnt1 peptide

    Wnt1 peptide

    Pharmacology - Drug Development Shirley (New York) February 22, 2019 Check with publisher

    The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during em...

  • Fully Synthetic Carbohydrate Based Cancer Vaccines

    Fully Synthetic Carbohydrate Based Cancer Vaccines

    Pharmacology - Drug Development Shirley (New York) January 28, 2019 Check with publisher

    Malignantly transformed cells often exhibit aberrant levels and types of cell surface carbohydrates, which are typically displayed as either glycoproteins or glycosphingolipids. Through exposure of the immune system to appropriately presented tumor a...

  • MINA Peptide

    MINA Peptide

    Pharmacology - Drug Development Shirley (New York) January 22, 2019 Check with publisher

    MINA is a c-Myc (MYC; MIM 190080) target gene that may play a role in cell proliferation or regulation of cell growth. (Tsuneoka et al., 2002 [PubMed 12091391]; Zhang et al., 2005 [PubMed 15897898]). https://www.creative-diagnostics.com/MINA-Peptide-...

  • Monoclonal Antibody Vaccines

    Monoclonal Antibody Vaccines

    Pharmacology - Drug Development Shirley (New York) December 26, 2018 Check with publisher

    Monoclonal antibodies (mAb or moAb) are antibodies made from the same immunocytes, which are clones of a single ancestral cell. Monoclonal antibodies bind to the same epitope, so they have monovalent affinity with identical offspring of a hybridoma o...

  • GMP Vaccine Production

    GMP Vaccine Production

    Pharmacology - Drug Development Shirley (New York) December 26, 2018 Check with publisher

    For years, Creative Biolabs has consistently and effectively supported the vaccine industry with a unique range of products and related services. We provide process development and GMP manufacturing services to support your vaccine development and co...